Checklist · Cannabis · Infused-Product Manufacturing

Infuser / Manufacturing (Infused-Products) Compliance Checklist

Follow one batch from the licensed premises and approved inputs through formulation, testing, release, packaging, state tracking, and transfer.

By Lincoln Square Law · 7-minute read

🖨 Print this checklist

• Production rooms, ingredient storage, quarantine areas, finished-goods storage, and waste areas are within the approved premises and access-controlled.
• Any equipment, room, ownership, or operational change that requires regulator approval was approved before implementation.

Control ingredients, formulations, and production records

A defensible batch file should let a reviewer reconstruct what went into the product and why. Tie cannabis inputs to state tracking identifiers, non-cannabis ingredients to receiving and lot records, and the finished formula to the approved product specification. Record actual weights, yields, losses, rework, and deviations rather than replacing expected values after production. If an allergen, food-safety, or contamination control applies, document the preventive step and the record showing it occurred.

• Each cannabis input is received from an authorized source, entered in the state tracking system, and linked to the production batch.
• Non-cannabis ingredients have supplier, lot, expiration, allergen, and receiving records appropriate to the product.
• Master formulations identify target potency, serving size, batch size, critical process steps, and permitted tolerances.
• Operators record actual weights, yields, losses, rework, hold decisions, and deviations contemporaneously.

Separate production from release authority

Manufacturing completion is not the same as release to commerce. Illinois requires testing before regulated cannabis is packaged for sale, and product labels must support traceability and recalls. Missouri likewise separates production, testing status, packaging, labeling, and track-and-trace records. Build a positive-release control: finished product remains physically and electronically on hold until the authorized reviewer confirms required testing, packaging, labeling, and state-system status.

• Finished product is quarantined until required testing and release criteria are complete.
• The release reviewer verifies the correct COA, batch or lot identity, potency, contaminant results, package configuration, and state-system status.
• Labels match the released product and include the identifiers needed to connect the package to the manufacturing and testing record.

Reconcile inventory at every conversion point

Manufacturing converts one regulated inventory form into another. That creates predictable reconciliation points: input issued to production, material actually consumed, work in process, finished output, samples, waste, retained material, and rework. Review those points against the state tracking system and physical inventory. Variances should trigger documented investigation rather than unexplained manual adjustments.

• Input quantities issued to production reconcile to consumption, output, samples, waste, and any authorized rework.
• State tracking entries are made at the required operational point, not reconstructed at the end of the week.
• Inventory adjustments have reason codes, supporting evidence, approval, and follow-up when the variance is material or recurring.

Audit sanitation, equipment, and personnel controls

Product safety failures often originate outside the formulation itself. The file should show cleaning status, equipment maintenance and calibration, pest controls, employee hygiene and protective practices, line clearance, and training.

For edible or food-like products, food-safety supervision and allergen controls should be treated as production controls rather than general housekeeping. A regulator should be able to see not only the policy but the dated evidence that the control was performed on the batch day.

• Pre-operational sanitation and line-clearance checks are complete before each production run.
• Scales, thermometers, mixers, filling equipment, and other critical equipment have current calibration or maintenance records.
• Employees assigned to manufacturing have current cannabis-agent credentials and documented task-specific training.

Close the batch with an audit-ready record

Before the batch is treated as closed, assemble the manufacturing record, state-system history, testing documentation, label version, packaging count, disposition of waste and samples, deviation records, and transfer record. Then perform a second-person review. The most useful question is whether someone who did not participate in production could reconstruct the batch without interviewing the production team. If not, the record is incomplete even if the product is commercially acceptable.

Test one deviation from discovery through closure

Deviation handling shows whether the quality system can distinguish a documented exception from an undocumented workaround. Select a recent production deviation: an unexpected yield, equipment alarm, temperature excursion, ingredient substitution, potency variance, sanitation miss, label mismatch, or packaging defect. Confirm who stopped or continued the process, what material was placed on hold, what facts were collected, who decided disposition, and whether the state inventory record remained accurate. If the deviation affected product identity, testing, safety, or traceability, the review should show why the batch remained eligible for release or why it was rejected.

• Select a real deviation and confirm the investigation identifies cause, affected product, disposition decision, and approver.
• Verify any rework was authorized by procedure and remains linked to the original batch.
• Confirm final release relied on post-deviation evidence rather than the production schedule.

Compare the label master to the package actually shipped

Label control is especially vulnerable to version drift. Pull the approved label master, the printed label from a retained or current package, and the state product record. Compare product name, cannabinoid information, batch or serial identifiers, warnings, net contents, dates, testing references, and any required manufacturer information. Then verify the artwork file is controlled so an employee cannot print an obsolete version after a formula, potency, or regulatory change. Where multiple SKUs share similar packaging, line-clearance and label reconciliation should prevent the wrong label from being applied to an otherwise compliant batch.

• Printed label version matches the released version for that SKU and batch.
• Unused, obsolete, or damaged labels are controlled and reconciled against accidental use.
• Packaging review confirms closure, tamper evidence where applicable, count, and alignment with the state record.

Run a one-batch trace in both directions

Traceability should work backward from a finished package to every regulated input and forward from an input to every finished package that used it. Time the exercise. A strong system can identify the relevant records quickly without reconstructing them from memory. Include the state tracking history, internal batch record, COA, label, transfer records, ingredient lots, waste, and any deviation or complaint information. Record gaps as corrective actions with an owner and deadline.

Review complaints and returns as manufacturing data

Customer complaints, dispensary returns, failed deliveries, and product holds can reveal manufacturing weaknesses before an inspection does. Trend them by SKU, batch, defect type, and production line. A recurring leak, label problem, inconsistent fill weight, delayed effect complaint, or foreign-material report should be connected back to batch records and equipment history. Define when a complaint triggers investigation, retained-sample review, additional testing, regulator analysis, or a recall assessment. The complaint file should identify the product precisely enough to connect the report to the affected production record.

• Complaints and returns are trended by SKU, batch, defect type, and recurrence.
• Escalation criteria identify when quality, compliance, or legal counsel must review the issue.
• Retained samples and production records are available when an investigation requires them.

Close with management review

At least periodically, management should review manufacturing deviations, inventory variances, complaints, failed or held batches, sanitation findings, testing trends, and corrective actions together. The purpose is to identify systemic risk that individual departments may not see. Record the decisions, owners, and deadlines, then verify completion at the next review. This creates a governance record showing that compliance information reaches people with authority to correct the process.